Dendritische Zellen - Dr. Kübler GmbH

ins. J Exper Med 1991;
173:273-6.
9. Sahin U, Tureci o, Pfreundschuh
M. Serological identification
of human antigens.
Curr Opin Immunol 1997;
9:709-16.
10.Jager E, Chen YT, Drijfhout
JW, Karbach J, et al. Simultaneous
humoral and cellular
immune response against
cancer-testis antigen NY-
ESO: definition of human histocompatibility
leukocyte
antigen (HLA)-A2-binding
peptide epitopes. J Exper
Med 1998; 187:265-70.
11.Gilboa E. The makings of a
tumor rejection antigen. Immunity
1999; 11:263-70.
12.Steinmann RM. The dendritic
cell system and ist role in immunogenicity.
Ann Rev Immunol
1991; 9:271-96.
13.Reid CD, Fryer PR, Clifford
C, Kirk A, et al. Identification
of hematopoietic progenitors
of macrophages and dendritic
Langerhans cells (DL-
CFU) in human bone marrow
and peripheral blood. Blood
1990; 76:1139-49.
14.Szaboles P, Avigan D, Gezelter
S, Ciocon DH,et al. Dendritic
cells and macrophages
can mature independently
from a human bone marrowderived,
post-forming unit intermediate.
Blood 1996;
87:4520-30.
15.Flores-Romo L. In vivo maturation
and migration of
dendritic cells. Immunol
2001; 102:255-62.
16.Inaba K, Inaba M, Naito M,
Steinmann RM. Dendritic
cell progenitors phagocytose
particulates, including bacillus
Calmette-Guerin organisms,
and sensitize mice to
mycobacterial antigens in
vivo. J Exper Med 1993;
178:479-88.
17.Sallusto F. Cella M, Danieli
C, Lanzavecchia A. Dendritic
cells use macropinocytosis
and the mannose receptor to
concentrate macromolecules
in the major histocompatibility
complex class II compartment:
downregulation by cytokines
and bacterial products.
J Exper Med 1995;
182:289-400.
18.Jiang W, Swiggard WJ,
Heufler C, Peng M, et al. The
receptor DEC-205 expressed
by dendritic cells and thymic
epithelial cells is involved in
antigen processing. Nature
1995; 375:151-5.
19.Stockl J, Majdic O, Kohl P,
Pickl WF, et al. Leukosialin
(CD43)-major histocompatibility
class I molecule interactions
involved in spontaneous
T cell conjugate formation.
J Exper Med 1996;
184:1769-79.
20.Salomon B, Bluestone JA.
LFA-1 interaction with
ICAM-1 and ICAM-2 regulates
Th2 cytokine production.
J Immunol 1998;
161:5138-42.
21.Tseng SY, Otsuji M, Gorski
K, Huang X, et al. B7-DC, a
new dendritic cell molecule
with potent costimulatory
properties for T cells. J Exper
Med 2001; 193:839-46.
22.Chen AI, McAdam AJ, Buhlmann
JE, Scott S, et al.
Ox40-ligand has a critical costimulatory
role in dendritic
cell: T cell interactions. Immunity
1999; 11:689-98.
23.Lapointe R, Toso JF, Butts
C, Young HA, et al. Human
dendritic cells require multiple
activation signals for the
efficient generation of tumor
antigen-specific T lymphocy-
tes. Immunol J Immunol
2000; 30:3291-8.
24.Cella M, Scheidegger D, Palmer-Lehmann
K, Lane P, et
al. Ligation of CD40 on dendritic
cells triggers production
of high levels of interleukin-l2
and enhances T cell
stimulatory capacity: T-T
help via APC activation. J
ExperMed 1996; 184:747-52.
25.Schwartz RH, T cell clonal
anergy. Curr Opin Immunol
1997; 9:351-7.
26.Thompson CB, Allison JP.
The emerging role of
CTLA-4 as an immune attenuator.
Immunity 1997;
7:445-50.
27.Elliott BE, Carlow DA, Rodricks
AM, Wade A. Perspectives
on the role of MHC antigens
in normal and malignant
cell development. Adv
Cancer Res 1989;
53:181-245.
28.Wang Z, Margulies L, Hicklin
DJ, Ferrone S. Molecular
and functional phenotypes of
melanoma cells with abnormalities
in HLA class I antigen
expression. Tissue Antigens
1996; 47:382-90.
29.Restifo NP, Esquivel F, Kawakami
Y, Yewdell JW, et
al. Identification of human
cancers deficient in antigen
processing. J Exper Med
1993; 177:265-72.
30.Chen L, Ashe S, Brady WA,
Hellstrom I, et al. Costimulation
of antitumor immunity
by the B7 counterreceptor for
the T lymphocyte molecules
CD28 and CTLA-4. Cell
1992; 71:1093-102.
31.Townsend SE, Allison JP.
Tumor rejection after direct
costimulation of CD8+ T
cells by B7-transfected melanoma
cells. Science 1993;
259:368-70.